Shockwave L6 Peripheral IVL Catheter

Large vessel treatment

8.0, 9.0, 10.0 & 12.0mm diameter sizes

Consistent high energy

Compact emitter design

Focused treatment

30mm balloon length

Support you need

.018” guidewire

Ultra-Low Pressure

IVL therapy at 2-4 atm

View Tech Sheet

See Shockwave L⁶ in Action

Calcified Bilateral Iliacs: Preserving the Bifurcation

Pre-Procedural Angio

IVUS Measurements:

LCIA: 11.7 x 10.9mm

RCIA: 10.3 x 11mm

IVL Treatment Angio

Shockwave L⁶ 12.0mm

150 pulses each side

Final Angio

No vessel recoil, bifurcation preserved

Calcified Bilateral Iliacs: Prepping for Stents

Diagnostic Angiogram

Diameter Stenosis:

RCIA:100% (concentric calcium)

LCIA: 80% (eccentric calcium)

IVL Therapy

Kissing Shockwave L⁶ 8.0mm

RCIA: 180 pulses, 70mm

LCIA: 120 pulses, 60mm

Post-IVL

Diameter Stenosis Post-IVL:

RCIA:0%

LCIA: 15%

Final Angiogram

Fully expanded VBX stents

Diameter stenosis in both RCIA & LCIA: 0%

Calcified Common Femoral Artery: Restoring In-Line Flow

Diagnostic Angiogram

100% stenosis

Post-Atherectomy

Orbital Atherectomy

Retrograde Access

US guided retrograde PFA access with .018” catheter & wire

IVL Therapy

Shockwave L⁶ 9.0mm in CFA after PTA, IVL and DCB in PFA

Final Angiogram

No dissections or perforations

No stents placed

Shockwave L⁶ Specifications

BALLOON DIAMETER (mm)	BALLOON LENGTH (mm)	SHEATH COMPATIBILITY (Fr)	CATHETER WORKING LENGTH (cm)	PULSES/ CYCLE	CYCLES	MAX PULSES	BALLOON CROSSING PROFILE (in)	GUIDEWIRE COMPATIBILITY (in)
8.0	30	7	110	30	10	300	0.086	0.018
9.0	30	7	110	30	10	300	0.087	0.018
10.0	30	8	110	30	10	300	0.091	0.018
12.0	30	8	110	30	10	300	0.093	0.018

BALLOON DIAMETER (mm)	BALLOON LENGTH (mm)	SHEATH COMPATIBILITY (Fr)	CATHETER WORKING LENGTH (cm)
8.0	30	7	110
9.0	30	7	110
10.0	30	8	110
12.0	30	8	110

BALLOON DIAMETER (mm)	PULSES/ CYCLE	CYCLES	MAX PULSES	BALLOON CROSSING PROFILE (in)	GUIDEWIRE COMPATIBILITY (in)
8.0	30	10	300	0.086	0.018
9.0	30	10	300	0.087	0.018
10.0	30	10	300	0.091	0.018
12.0	30	10	300	0.093	0.018

Peripheral IVL: backed by sound Clinical Evidence

DISRUPT PAD III OS: the largest prospective ‘real-world’ evidence for the treatment of complex, heavily calcified PAD

1,373

Patients

1,531

Lesions

30

Sites

3

Countries

EXPLORE DISRUPT PAD OS DATA

EXPANDING Peripheral IVL Reimbursement in 2023

Peripheral IVL has reimbursement in the outpatient, Ambulatory Surgical Centers (ASC) and inpatient setting. The beginning of 2023 brings further progress with the Medicare payment increases for IVL in the treatment of iliac, femoral and popliteal arteries in the ASC setting.

LEARN MORE